Directory Affiliates and Chapters

Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

Starting Patrol Heading for the bicycle Tom Jensen starts on his daily patrol to search out used syringes left on the streets last night. First Check The yellow jacket marked “Sprøjte Patruljen” lets the community know that they are safe and BF is on the job picking up used syringes and other paraphernalia. A Syringe…

The First Patient Advocate’s Illumination Award Sunday, October 7th The Advocate’s Illumination Award is presented to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment. Inscription The Opioid Agonist Treatment Advocacy Community with heartfelt thanks and…

Northern California NAMA Discussion List Jump Page Moderator: Rokki Baker, CMA Director, NAMA Nor Cal Chapter Coordinator & Board of Directors, NAMA This is the webpage of the Northern California NAMA. Here you will find Methadone Patients helping other’s with CA’s Reg’s and who to contact when you feel your Program has made an error…

FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…